 |
0 Diseases |  |
30 Trials |
|
30 Trials |  |
4896 News |  |
| «12...64656667686970717273747576 |
- ||| lacosamide / Generic mfg.
Trial completion: Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects (clinicaltrials.gov) - Jan 22, 2014
P1, N=60, Completed, Sponsor: UCB, Inc.
Active, not recruiting --> Completed
- | levetiracetam / Generic mfg., carbamazepine / Generic mfg.
New P4 trial, Surgery: TTS (Time To Stop) Trial (EUDRACT) - Dec 29, 2013
P4, N=180, Ongoing, Sponsor: University Medical Center Utrecht
- lacosamide / Generic mfg.
Trial termination: VICTOR: Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide (clinicaltrials.gov) - Dec 9, 2013
P3, N=11, Terminated, Sponsor: UCB, Inc.
Active, not recruiting --> Completed Recruiting --> Terminated; Slow progress despite recruitment boosting efforts e.g., expert advice obtained from leading study center Investigators; decision thus made to terminate.
- lacosamide / Generic mfg.
Enrollment change: VICTOR: Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide (clinicaltrials.gov) - Dec 9, 2013
P3, N=11, Terminated, Sponsor: UCB, Inc.
Recruiting --> Terminated; Slow progress despite recruitment boosting efforts e.g., expert advice obtained from leading study center Investigators; decision thus made to terminate. N=28 --> 11
- |||||||||| levetiracetam / Generic mfg., carbamazepine / Generic mfg.
New P3 trial, Monotherapy: Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures (clinicaltrials.gov) - Sep 29, 2013
P3, N=436, Recruiting, Sponsor: UCB Pharma SA
- carbamazepine / Generic mfg.
Trial completion: LICAVAL: Efficacy of Combined Treatment for Young Bipolar I Disorder (clinicaltrials.gov) - Jul 9, 2013
P4, N=40, Completed, Sponsor: University of Sao Paulo
N=28 --> 11 Recruiting --> Completed
- | citalopram / Generic mfg.
Enrollment closed: Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram (clinicaltrials.gov) - Jun 10, 2013
P2/3, N=150, Active, not recruiting, Sponsor: Tufts Medical Center
Recruiting --> Completed Recruiting --> Active, not recruiting
- carbamazepine / Generic mfg.
Trial completion, Adverse drug reaction: Pathogenesis of Adverse Drug Reactions (clinicaltrials.gov) - Apr 28, 2013
P=N/A, N=98, Completed, Sponsor: Children's Mercy Hospital Kansas City
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- || lacosamide / Generic mfg.
Trial initiation date: Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects (clinicaltrials.gov) - Feb 27, 2013
P1, N=60, Completed, Sponsor: UCB, Inc.
Active, not recruiting --> Completed Initiation date: Feb 2012 --> May 2012
- |||| carbamazepine / Generic mfg.
Trial completion: The Young Adult and Pediatric Bipolar Study (clinicaltrials.gov) - Feb 7, 2013
P4, N=161, Completed, Sponsor: Validus Pharmaceuticals
Initiation date: Feb 2012 --> May 2012 Active, not recruiting --> Completed
- ||||| zonisamide / Generic mfg.
Enrollment change, Monotherapy: Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures (clinicaltrials.gov) - Jan 9, 2013
P3, N=295, Completed, Sponsor: Eisai Inc.
Active, not recruiting --> Completed N=580 --> 295
- ||||||| zonisamide / Generic mfg.
Trial completion, Monotherapy: Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures (clinicaltrials.gov) - Jan 9, 2013
P3, N=295, Completed, Sponsor: Eisai Inc.
N=580 --> 295 Active, not recruiting --> Completed
- | ketoconazole / Generic mfg., carbamazepine / Generic mfg., pomalidomide / Generic mfg.
Clinical: A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects (clinicaltrials.gov) - Dec 2, 2012
P1, N=32, Completed, Sponsor: Celgene Corporation
Active, not recruiting --> Completed Recruiting --> Completed
- | ketoconazole / Generic mfg., carbamazepine / Generic mfg., pomalidomide / Generic mfg.
Clinical: A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects (clinicaltrials.gov) - Oct 14, 2012
P1, N=32, Completed, Sponsor: Celgene Corporation
- carbamazepine / Generic mfg.
Enrollment open: Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency (clinicaltrials.gov) - Oct 8, 2012
P2, N=30, Recruiting, Sponsor: University of Pittsburgh
Recruiting --> Completed Not yet recruiting --> Recruiting
- | Incivek (telaprevir) / J&J, Vertex, Mitsubishi Tanabe
Trial completion: A Study to Investigate the Potential Pharmacokinetic Interactions Between Phenytoin or Carbamazepine and Telaprevir (clinicaltrials.gov) - Sep 19, 2012
P1, N=24, Completed, Sponsor: Janssen Infectious Diseases BVBA
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | basimglurant (NOE-101) / Noema Pharma
Trial completion: A Study of the Effect of Carbamazepine on the Pharmacokinetics of RO4917523 in Healthy Volunteers (clinicaltrials.gov) - Sep 18, 2012
P1, N=16, Completed, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed Recruiting --> Completed
- | lacosamide / Generic mfg.
Trial completion: Effects of Lacosamide on Human Motor Cortex Excitability: a Transcranial Magnetic Stimulation Study (clinicaltrials.gov) - Aug 27, 2012
P=N/A, N=18, Completed, Sponsor: University of Kiel
Recruiting --> Completed Recruiting --> Completed
- | Incivek (telaprevir) / J&J, Vertex, Mitsubishi Tanabe
New P1 trial: A Study to Investigate the Potential Pharmacokinetic Interactions Between Phenytoin or Carbamazepine and Telaprevir (clinicaltrials.gov) - Jul 8, 2012
P1, N=24, Completed, Sponsor: Janssen Infectious Diseases BVBA
- | basimglurant (NOE-101) / Noema Pharma
New P1 trial: A Study of the Effect of Carbamazepine on the Pharmacokinetics of RO4917523 in Healthy Volunteers (clinicaltrials.gov) - Jun 25, 2012
P1, N=16, Completed, Sponsor: Hoffmann-La Roche
- carbamazepine / Generic mfg.
New P2 trial, CINV: Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting (clinicaltrials.gov) - Apr 18, 2012
P2, N=43, Recruiting, Sponsor: Faculdade de Medicina do ABC
- levetiracetam / Generic mfg., carbamazepine / Generic mfg.
Trial completion: Photosensitivity Proof of Concept Trial (clinicaltrials.gov) - Feb 29, 2012
P2, N=6, Completed, Sponsor: The Epilepsy Study Consortium
Recruiting --> Completed Active, not recruiting --> Completed
- ||| lacosamide / Generic mfg.
New P1 trial: Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects (clinicaltrials.gov) - Feb 7, 2012
P1, N=60, Completed, Sponsor: UCB, Inc.
- carbamazepine / Generic mfg.
Trial initiation date: Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency (clinicaltrials.gov) - Jan 3, 2012
P2, N=30, Recruiting, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Initiation date: Oct 2011 --> Jan 2012
- |||| lamotrigine liquid oral suspension / OWP Pharma
Trial completion: STEP-ONE: Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs (clinicaltrials.gov) - Dec 1, 2011
P4, N=361, Completed, Sponsor: Johannes Gutenberg University Mainz
Initiation date: Oct 2011 --> Jan 2012 Active, not recruiting --> Completed
- |||||||||| lacosamide / Generic mfg., carbamazepine / Generic mfg.
New P3 trial, Monotherapy: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older (clinicaltrials.gov) - Nov 3, 2011
P3, N=527, Recruiting, Sponsor: UCB BIOSCIENCES GmbH
- | bitopertin (DISC-1459) / Disc Medicine
Trial completion: A Study on The Effect of Multiple Dose Carbamazepine on Single Dose Pharmacokinetics of RO4917838 in Healthy Volunteers (clinicaltrials.gov) - Sep 18, 2011
P1, N=16, Completed, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed Recruiting --> Completed